Table 3.
Chemical shift (ppm) | Compound/functional group | VPA | THAL | ||||
---|---|---|---|---|---|---|---|
% of control | ANOVA | VIP value | % of control | ANOVA | VIP value | ||
6.87 | Unassigned 1 | 85 | F(1,21) = 2.920 | 1.06 | 86 | F(1,23) = 1.665 | |
p = 0.103 | p = 0.210 | ||||||
6.09 | (–HC(2,4)=) Estriol | 78 | F(1,21) = 5.222 | 1.35 | 71 | F(1,23) = 9.735 | 1.37 |
p = 0.033* | p = 0.005* | ||||||
5.87 | (–C(4)H=C(5)H–) Testosterone | 165 | H(1) = 0.683 | 2.27 | 53 | H(1) = 1.137 | 1.52 |
p = 0.407 | p = 0.286 | ||||||
5.14 | (–HC=CH–) Olefinic group in MUFA | 93 | F(1,21) = 0.228 | 96 | H(1) = 4.720 | 1.35 | |
p = 0.638 | p = 0.030* | ||||||
5.03 | Unassigned 2 | 82 | F(1,21) = 0.690 | 1.67 | 117 | F(1,23) = 0.582 | 1.16 |
p = 0.416 | p = 0.454 | ||||||
4.70 | Unassigned 3 | 68 | H(1) = 2.804 | 1.54 | 112 | H(1) = 0.0680 | |
p = 0.794 | |||||||
p = 0.094 | |||||||
4.15 | (–C(2)H–) Sphingomyelin (d18:1/16:0) | 103 | F(1,21) = 0.0719 | 119 | F(1,23) = 2.359 | ||
p = 0.139 | |||||||
p = 0.791 | |||||||
3.88 | (–CH2–CH2–N(–CH3)3) L-α-Phosphatidylcholine (16:0/18:2) | 104 | F(1,21) = 0.145 | 124 | H(1) = 3.123 | ||
p = 0.708 | p = 0.077 | ||||||
3.68 | (ROCH2–CHOH–CH2OH) in glyceryl group in 1-MG | 112 | F(1,21) = 0.556 | 145 | F(1,23) = 7.328 | 1.10 | |
p = 0.465 | p = 0.013* | ||||||
3.24 | (–O–CH2–CH2–NH3) L-α-Phosphatidylethanolamine (18:0/18:0) | 91 | F(1,21) = 0.515 | 101 | F(1,23) = 0.00762 | ||
p = 0.483 | |||||||
p = 0.932 | |||||||
2.30 | (–OCO–CH2–), (–COOH–CH2–) Acyl groups in 1,3-DG, 1-MG, and FA | 107 | F(1,21) = 0.262 | 93 | F(1,23) = 0.225 | ||
p = 0.614 | p = 0.643 | ||||||
2.22 | (–C(α)H2–) in saturated FA, MUFA, and PUFA | 64 | F(1,21) = 11.580 | 1.60 | 61 | F(1,23) = 10.494 | 1.37 |
p = 0.005* | |||||||
p = 0.003* | |||||||
2.00 | (–CH2–CH=CH–) in acyl groups of FA and phospholipids | 88 | F(1,21) = 1.093 | 103 | F(1,23) = 0.0717 | ||
p = 0.310 | p = 0.792 | ||||||
1.70 | (–C(15)H2–) Palmitic acid in L-α- lysophosphatidylcholine and FA | 84 | H(1) = 2.381 | 1.17 | 140 | H(1) = 3.545 | 1.07 |
p = 0.123 | p = 0.060 | ||||||
1.60 | (–OCO–CH2–CH2–) in acyl groups in 1,3-DG, 1-MG, and FA | 89 | F(1,21) = 1.516 | 106 | F(1,23) = 0.359 | ||
p = 0.233 | p = 0.555 | ||||||
1.28 | (−(CH2)n–) in acyl groups in FA | 95 | F(1,21) = 0.365 | 106 | F(1,23) = 0.509 | ||
p = 0.552 | p = 0.483 | ||||||
1.08 | (–C(21)H3) Cholestenol | 101 | F(1,21) = 0.0148 | 124 | p = 0.029* | ||
p = 0.904 | |||||||
0.98 | (–C(ω)H3) in PUFA/MUFA | 108 | F(1,21) = 0.385 | 131 | F(1,23) = 6.927 | 1.21 | |
p = 0.542 | p = 0.015* | ||||||
0.93 | (–C(21)H3) Free cholesterol and 25-hydroxycholesterol | 104 | F(1,21) = 0.118 | 125 | F(1,23) = 6.076 | 1.10 | |
p = 0.734 | p = 0.022* | ||||||
0.88 | (–CH3) in acyl groups of FA and sterols | 93 | F(1,21) = 1.000 | 107 | F(1,23) = 0.805 | ||
p = 0.329 | p = 0.379 | ||||||
0.72 | (–C(18)H3) 24-Hydroxycholesterol | 70 | H(1) = 7.788 | 1.34 | 83 | F(1,23) = 2.228 | |
p = 0.005* | p = 0.150 | ||||||
0.69 | (–C(18)H3) Free cholesterol and cholesterol esters | 103 | F(1,21) = 0.0971 | 121 | F(1,23) = 5.099 | 1.00 | |
p = 0.034* | |||||||
p = 0.759 | |||||||
0.62 | (–C(18)H3) Progesterone | 87 | F(1,21) = 0.233 | 1.03 | 113 | F(1,23) = 0.240 | 1.28 |
p = 0.635 | p = 0.629 | ||||||
0.53 | (–C(18)H3) Lathosterol | 108 | F(1,21) = 0.950 | 115 | F(1,23) = 2.759 | ||
p = 0.341 | p = 0.111 |
Only VIP values > 1 obtained in MVA analysis are presented
*Statistically significant